{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:26:24Z","timestamp":1750289184003,"version":"3.37.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010547","name":"Faculty of Medicine, Assiut University","doi-asserted-by":"publisher","award":["grant # R3-2015."],"award-info":[{"award-number":["grant # R3-2015."]}],"id":[{"id":"10.13039\/501100010547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12010-019-03017-x","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T06:02:35Z","timestamp":1555308155000},"page":"330-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients"],"prefix":"10.1007","volume":"189","author":[{"given":"Ragaa H.","family":"Salama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zain El-Abdeen A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Ashmawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael A.","family":"Elsewify","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-6339","authenticated-orcid":false,"given":"Ghada M.","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya A.","family":"Alsanory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasneem A.","family":"Alsanory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"issue":"7","key":"3017_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.bbadis.2014.02.006","volume":"1842","author":"AG Vaiopoulos","year":"2014","unstructured":"Vaiopoulos, A. G., Athanasoula, K. C., & Papavassiliou, A. G. (2014). Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges. Biochim cal Biophys Acta - Mol Basis Dis, 1842(7), 971\u2013980.","journal-title":"Biochim cal Biophys Acta - Mol Basis Dis"},{"key":"3017_CR2","doi-asserted-by":"crossref","unstructured":"Perera, A.P., Sajnani, K., Dickinson, J., Eri, R., & K\u00f6rner, H. (2018). NLRP3 inflammasome in colitis and colitis- associated colorectal cancer. Mamm Genome, (11-12), 817\u2013830.","DOI":"10.1007\/s00335-018-9783-2"},{"issue":"29","key":"3017_CR3","doi-asserted-by":"publisher","first-page":"9872","DOI":"10.3748\/wjg.v20.i29.9872","volume":"20","author":"ER Kim","year":"2014","unstructured":"Kim, E. R., & Chang, D. K. (2014). Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World Journal of Gastroenterology, 20(29), 9872\u20139881.","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"3017_CR4","first-page":"933","volume":"31","author":"T Tahara","year":"2011","unstructured":"Tahara, T., Shibata, T., Nakamura, M., Okubo, M., Yamashita, H., Yoshioka, D., Yonemura, J., Kmiya, Y., Ishizuka, T., Fujita, H., Nagasaka, M., Yamada, H., Hirata, I., & Arisawa, T. (2011). Host genetic factors, related to inflammatory response, influence the CpG island methylation status in colonic mucosa in ulcerative colitis. Anticancer Research, 31(3), 933\u2013938.","journal-title":"Anticancer Research"},{"issue":"1","key":"3017_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-018-0505-0","volume":"10","author":"T Dziaman","year":"2018","unstructured":"Dziaman, T., Gackowski, D., Guz, J., Linowiecka, K., Bodnar, M., Starczak, M., Zarakowska, E., Modrzejewska, M., Szpila, A., Szpotan, J., Gawronski, M., Labejszo, A., Liebert, A., Banaszkiewicz, Z., Klopocka, M., Foksinski, M., Marszalek, A., & Olinski, R. (2018). Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel disease. Clinical Epigenetics, 10(1), 1\u201311.","journal-title":"Clinical Epigenetics"},{"issue":"1","key":"3017_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1399-0004.2010.01546.x","volume":"80","author":"Z Lin","year":"2011","unstructured":"Lin, Z., Hegarty, J., Cappe, J., Yu, W., Chen, X., Faber, P., Wang, Y., Kelly, A. A., Portiz, L. P., & Peterson, B. Z. (2011). Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease. Clinical Genetics, 80(1), 59\u201367.","journal-title":"Clinical Genetics"},{"issue":"3","key":"3017_CR7","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0002-9440(10)61789-0","volume":"159","author":"A Rashid","year":"2001","unstructured":"Rashid, A., Shen, L., Morris, J. S., Issa, J. P., & Hamilton, S. R. (2001). CpG island methylation in colorectal adenomas. American Journal of Pathololog, 159(3), 1129\u20131135.","journal-title":"American Journal of Pathololog"},{"issue":"5","key":"3017_CR8","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/ijc.26484","volume":"31","author":"E Cassinotti","year":"2012","unstructured":"Cassinotti, E., Melson, J., Liggett, T., Melnikov, A., Yi, Q., Replogle, C., Mobarhan, S., Boni, L., Segato, S., & Levenson, V. (2012). DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps. International Journal of Cancer, 31(5), 1153\u20131157.","journal-title":"International Journal of Cancer"},{"issue":"18","key":"3017_CR9","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1242\/jcs.010389","volume":"120","author":"H Donninger","year":"2007","unstructured":"Donninger, H., Vos, M. D., & Clark, G. J. (2007). The RASSF1A tumor suppressor. Journal of Cell Science, 120(18), 3163\u20133172.","journal-title":"Journal of Cell Science"},{"issue":"2","key":"3017_CR10","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3390\/ijms16022472","volume":"16","author":"JMK Ng","year":"2015","unstructured":"Ng, J. M. K., & Yu, J. (2015). Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. International Journal Mololecular Science, 16(2), 2472\u20132496.","journal-title":"International Journal Mololecular Science"},{"key":"3017_CR11","first-page":"e12548.7","volume":"3","author":"T Chen","year":"2018","unstructured":"Chen, T., Yang, Z., Liu, C., Wang, L., Yang, J., Chen, L., & Li, W. (2018). Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330-3p. Cell Proliferation, 3, e12548.7.","journal-title":"Cell Proliferation"},{"key":"3017_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mrfmmm.2015.05.002","volume":"778","author":"I Balgkouranidou","year":"2015","unstructured":"Balgkouranidou, I., Matthaios, D., Karayiannakis, A., Bolanaki, H., Michailidis, P., Xenidis, N., Amarantidis, K., Chelis, L., Trypsianis, G., Chatzaki, E., Lianidou, E. S., & Kakolyris, S. (2015). Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Mutatation Researsh, 778, 46\u201351.","journal-title":"Mutatation Researsh"},{"key":"3017_CR13","doi-asserted-by":"crossref","unstructured":"Pasha, H.F., Mohamed, R. H., & Radwan, M.I. (2019). RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma. Cancer Biomarkers, 24(2), 241\u2013247.","DOI":"10.3233\/CBM-181638"},{"issue":"1","key":"3017_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12010-017-2648-4","volume":"185","author":"NA Rezk","year":"2018","unstructured":"Rezk, N. A., Mohamed, R. H., Alnemr, A. A., & Harira, M. (2018). Promoter methylation of RASSF1A gene in egyptian patients with ovarian cancer. Applied Biochemistry and Biotechnology, 185(1), 153\u2013162.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"3017_CR15","doi-asserted-by":"crossref","unstructured":"Cao, X., Tang, Q., Holland-Letz, T., G\u00fcndert, M., Cuk, K., Schott, S., Heil, J., Golatta, M., Sohn, C., Schneeweiss, A. & Burwinkel, B. (2018). Evaluation of promoter methylation of RASSF1A and ATM in peripheral blood of breast cancer patients and healthy control individuals. International Journal of Molecular Science, (900), 1\u201312.","DOI":"10.3390\/ijms19030900"},{"issue":"1","key":"3017_CR16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3892\/ol.2016.4649","volume":"12","author":"D Matthaios","year":"2016","unstructured":"Matthaios, D., Balgkouranidou, I., Karayiannakis, A., Bolanaki, H., Xenidis, N., Amarantidis, K., Chelis, L., Romanidis, K., Chatzaki, A., Lianidou, E., Trypsianis, G., & Kakolyris, S. (2016). Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer. Oncology Letter, 12(1), 748\u2013756.","journal-title":"Oncology Letter"},{"issue":"19","key":"3017_CR17","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.3748\/wjg.14.3074","volume":"14","author":"YC Wang","year":"2008","unstructured":"Wang, Y. C., Yu, Z. H., Liu, C., Xu, L. Z., Yu, W., Lu, J., Zhu, R. M., Li, G. L., Xia, X. Y., Wei, X. W., Ji, H. Z., Lu, H., Gao, Y., Gao, W. M., & Chen, L. B. (2008). Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World Journal of Gastroenterology, 14(19), 3074\u20133080.","journal-title":"World Journal of Gastroenterology"},{"issue":"7","key":"3017_CR18","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1002\/jcp.26332","volume":"233","author":"M Rivandi","year":"2018","unstructured":"Rivandi, M., Khorrami, M. S., Fiuji, H., Shahidsales, S., Hasanzadeh, M., Jazayeri, M. H., Hassanian, S. M., Ferns, G. A., Saghafi, N., & Avan, A. (2018). The 9p21 locus. A potential therapeutic target and prognostic marker in breast cancer. Journal of Cellular Physiology, 233(7), 5170\u20135179.","journal-title":"Journal of Cellular Physiology"},{"key":"3017_CR19","unstructured":"Tadesse, S., Caldon, E., Tilley, W., & Wang, S. (2018). Cyclin dependent kinase 2 inhibitors in cancer therapy: an update. Journal of Medicinal Chemistry."},{"issue":"5","key":"3017_CR20","doi-asserted-by":"publisher","first-page":"e12827","DOI":"10.1111\/acel.12827","volume":"17","author":"R Mikawa","year":"2018","unstructured":"Mikawa, R., Suzuki, Y., Baskoro, H., Kanayama, K., Sugimoto, K., Sato, T., & Sugimoto, M. (2018). Elimination of p19ARF-expressing cells protects against pulmonary emphysema in mice. Aging Cell, 17(5), e12827.","journal-title":"Aging Cell"},{"issue":"3","key":"3017_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/CBM-171156","volume":"22","author":"MA Mekky","year":"2018","unstructured":"Mekky, M. A., Salama, R. H., Abdel-Aal, M. F., Ghaliony, M. A., & Zaky, S. (2018). Studying the frequency of aberrant DNA methylation of APC, P14, and E-cadherin genes in HCV-related hepatocarcinogenesis. Cancer Biomark, 22(3), 503\u2013509.","journal-title":"Cancer Biomark"},{"issue":"8","key":"3017_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1349-7006.2002.tb01333.x","volume":"93","author":"K Hibi","year":"2002","unstructured":"Hibi, K., Nakayama, H., Koike, M., Kasai, Y., Ito, K., Akiyama, S., & Nakao, A. (2002). Colorectal cancers with both p16 and p14 methylation show invasive characteristics. Jpn J Cancer Res, 93(8), 883\u2013887.","journal-title":"Jpn J Cancer Res"},{"issue":"5","key":"3017_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3349\/ymj.2018.59.5.588","volume":"59","author":"SH Kim","year":"2018","unstructured":"Kim, S. H., Park, K. H., Shin, S. J., Lee, K. Y., Kim, T. I., Kim, N. K., Rha, S. Y., & Ahn, J. B. (2018). CpG island methylator phenotype and methylation of Wnt pathway genes together predict survival in patients with colorectal cancer. Yonsei Medical Journal, 59(5), 588\u2013594.","journal-title":"Yonsei Medical Journal"},{"issue":"2","key":"3017_CR24","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s13277-013-1198-9","volume":"35","author":"I Chaar","year":"2014","unstructured":"Chaar, I., Amara, S., Elamine, O. E., Khiari, M., Ounissi, D., Khalfallah, T., Ben Hmida, A., Mzabi, S., & Bouraoui, S. (2014). Biological significance of promoter hypermethylation of p14\/ARF gene: relationships to p53 mutational status in Tunisian population with colorectal carcinoma. Tumour Biology, 35(2), 1439\u20131449.","journal-title":"Tumour Biology"},{"issue":"20","key":"3017_CR25","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1158\/1078-0432.CCR-07-1011","volume":"13","author":"L Shen","year":"2007","unstructured":"Shen, L., Catalano, P. J., Benson, A. B., O'Dwyer, P., Hamilton, S. R., & Issa, J. P. (2007). Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clinical Cancer Research, 13(20), 6093\u20136098.","journal-title":"Clinical Cancer Research"},{"key":"3017_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biopha.2016.12.064","volume":"87","author":"V Das","year":"2017","unstructured":"Das, V., Kalita, J., & Pal, M. (2017). Predictive and prognostic biomarkers in colorectal cancer: systematic review of recent advances and challenges. Biomedicine & Pharmacotherapy, 87, 8\u201319.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"11","key":"3017_CR27","doi-asserted-by":"publisher","first-page":"e0188052","DOI":"10.1371\/journal.pone.0188052","volume":"12","author":"R Farahzadi","year":"2017","unstructured":"Farahzadi, R., Fathi, E., Mesbah-Namin, S. A., & Zarghami, N. (2017). Zinc sulfate contributes to promote telomere length extension via increasing telomerase gene expression, telomerase activity and change in the TERT gene promoter CpG island methylation status of human adipose-derived mesenchymal stem cells. PLoS ONE, 12(11), e0188052.","journal-title":"PLoS ONE"},{"issue":"1","key":"3017_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2407-8-61","volume":"8","author":"A Lorente","year":"2008","unstructured":"Lorente, A., Mueller, W., Urdangar\u00edn, E., L\u00e1zcoz, P., von Deimling, A., & Castresana, J. S. (2008). Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR. BMC Cancer, 8(1), 61.","journal-title":"BMC Cancer"},{"key":"3017_CR29","doi-asserted-by":"crossref","unstructured":"Farahzadi, R., Fathi, E., Mesbah-Namin, S.A., & Zarghami, N. (2018). Anti-aging protective effect of L-carnitine as clinical agent in regenerative medicine through increasing telomerase activity and change in the hTERT promoter CpG island methylation status of adipose tissue-derived mesenchymal stem cells. Tissue and Cel1, 54, 105\u2013113.","DOI":"10.1016\/j.tice.2018.08.012"},{"issue":"4","key":"3017_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11888-014-0245-2","volume":"10","author":"H Ashktorab","year":"2015","unstructured":"Ashktorab, H., & Brim, H. (2015). DNA methylation and colorectal cancer. Current Colorectal Cancer Reports, 10(4), 425\u2013430.","journal-title":"Current Colorectal Cancer Reports"},{"key":"3017_CR31","first-page":"9212","volume":"4","author":"JH Yoon","year":"2001","unstructured":"Yoon, J. H., Dammann, R., & Pfeifer, G. P. (2001). Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas. International Journal Cancer, 4, 9212\u20139217.","journal-title":"International Journal Cancer"},{"key":"3017_CR32","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1038\/sj.onc.1205922","volume":"21","author":"KJ Wagner","year":"2000","unstructured":"Wagner, K. J., Cooper, W. N., Grundy, R. G., Caldwell, G., Jones, C., Wadey, R. B., Morton, D., Schofield, P. N., Reik, W., Latif, F., & Maher, E. R. (2000). Frequent RASSF1A tumor suppressor gene promoter methylation in Wilms\u2019 tumor and colorectal cancer. Oncogene, 21, 7277\u20137282.","journal-title":"Oncogene"},{"key":"3017_CR33","first-page":"125","volume":"27","author":"PS Karatzas","year":"2014","unstructured":"Karatzas, P. S., Gazouli, M., Safioleas, M., & Mantzaris, G. J. (2014). DNA methylation changes in inflammatory bowel disease. Annals of Gastroenterology, 27, 125\u2013132.","journal-title":"Annals of Gastroenterology"},{"key":"3017_CR34","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s13277-011-0206-1","volume":"32","author":"HE Abouzeid","year":"2011","unstructured":"Abouzeid, H. E., Kassem, A. M., Wahab Abdel, A. H., El-mezayen, H. A., Sharad, H., & Abdel Rahman, S. (2011). Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors. Tumor Biology, 32, 845\u2013852.","journal-title":"Tumor Biology"},{"issue":"2","key":"3017_CR35","first-page":"2027","volume":"9","author":"WW Zheng","year":"2016","unstructured":"Zheng, W. W., Zhao, L. D., Wang, G. X., Kang, X. C., Qin, L., Ji, J. J., & Hao, S. (2016). Promoter methylation and expression of RASSF1A genes as predictors of disease progression in colorectal cancer. International Journal of Clinical and Experimental Medicineis, 9(2), 2027\u20132036.","journal-title":"International Journal of Clinical and Experimental Medicineis"},{"issue":"23","key":"3017_CR36","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1038\/sj.onc.1205466","volume":"21","author":"M Engeland van","year":"2002","unstructured":"van Engeland, M., Roemen, G. M., Brink, M., Pachen, M. M., Weijenberg, M. P., de Bru\u00efne, A. P., Arends, J. W., van den Brandt, P. A., de Goeij, A. F., & Herman, J. G. (2002). K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene, 21(23), 3792\u20133795.","journal-title":"Oncogene"},{"issue":"12","key":"3017_CR37","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1158\/1078-0432.CCR-12-3734","volume":"20","author":"AH Cleven","year":"2014","unstructured":"Cleven, A. H., Derks, S., Draht, M. X., Smits, K. M., Melotte, V., Van Neste, L., Tournier, B., Jooste, V., Chapusot, C., Weijenberg, M. P., et al. (2014). CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer. Clinical Cancer Research, 20(12), 3261\u20133271.","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"3017_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3892\/ijo.2012.1682","volume":"42","author":"TK Nilsson","year":"2013","unstructured":"Nilsson, T. K., Lof-Ohlin, Z. M., & Sun, X. F. (2013). DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients. International Journal Oncololy, 42(1), 127\u2013133.","journal-title":"International Journal Oncololy"},{"issue":"6","key":"3017_CR39","first-page":"456","volume":"96","author":"M Li","year":"2016","unstructured":"Li, M., Yan, D. G., & Liu, J. L. (2016). Methylation status of PCDH10 and RASSF1A gene promoters in colorectal cancer. Zhonghua Yi Xue Za Zh, 96(6), 456\u2013459.","journal-title":"Zhonghua Yi Xue Za Zh"},{"issue":"10","key":"3017_CR40","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.prp.2018.07.031","volume":"214","author":"H Hu","year":"2018","unstructured":"Hu, H., Zhou, C., Li, B., Chen, Y., Dai, J., Mao, Y., Huang, T., Yu, H., Chen, M., Zhao, J., & Duan, S. (2018). Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis. Pathology, Research and Practice, 214(10), 1572\u20131578.","journal-title":"Pathology, Research and Practice"},{"issue":"11","key":"3017_CR41","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1089\/gtmb.2012.0126","volume":"16","author":"SP Chen","year":"2012","unstructured":"Chen, S. P., Wu, C. C., Huang, S. Y., Kang, J. C., Chiu, S. C., Yang, K. L., & Pang, C. Y. (2012). Beta-catenin and K-ras mutations and RASSF1A promoter methylation in Taiwanese colorectal cancer patients. Genetic Testing and Moleclar Biomarkers, 16(11), 1277\u20131281.","journal-title":"Genetic Testing and Moleclar Biomarkers"},{"issue":"9","key":"3017_CR42","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1002\/ijc.25225","volume":"127","author":"B An","year":"2010","unstructured":"An, B., Kondo, Y., Okamoto, Y., Shinjo, K., Kanemitsu, Y., Komori, K., Hirai, T., Sawaki, A., Tajika, M., Nakamura, T., Yamao, K., Yatabe, Y., Fujii, M., Murakami, H., Osada, H., Tani, T., Matsuo, K., Shen, L., Issa, J. P., & Sekido, Y. (2010). Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers. International Journal of Cancer, 127(9), 2095\u20132105.","journal-title":"International Journal of Cancer"},{"issue":"10","key":"3017_CR43","doi-asserted-by":"publisher","first-page":"e75483","DOI":"10.1371\/journal.pone.0075483","volume":"8","author":"M Gordon","year":"2013","unstructured":"Gordon, M., El-Kalla, M., Zhao, Y., Fiteih, Y., Law, J., Volodko, N., Anwar-Mohamed, A., El-Kadi, A. O., Liu, L., Odenbach, J., Thiesen, A., Onyskiw, C., Ghazaleh, H. A., Park, J., Lee, S. B., Yu, V. C., Fernandez-Patron, C., Alexander, R. T., Wine, E., & Baksh, S. (2013). The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury. PLoS One, 8(10), e75483.","journal-title":"PLoS One"},{"key":"3017_CR44","doi-asserted-by":"publisher","unstructured":"Nterma, P., Panopoulou, E., Papadaki-Petrou, E., & Assimakopoulou, M. (2019). Immunohistochemical profile of tumor suppressor proteins RASSF1A and LATS1\/2 in relation to p73 and YAP Expression of human inflammatory bowel disease and normal intestine. Pathology Oncolology Research. \n                    https:\/\/doi.org\/10.1007\/s12253-018-00575-z\n                    \n                  .","DOI":"10.1007\/s12253-018-00575-z"},{"issue":"4","key":"3017_CR45","first-page":"1148","volume":"62","author":"F Sato","year":"2002","unstructured":"Sato, F., Harpaz, N., Shibata, D., Xu, Y., Yin, J., Mori, Y., Zou, T., Wang, S., Desai, K., Leytin, A., Selaru, F. M., Abraham, J. M., & Meltzer, S. J. (2002). Hypermethylation of the p14 ARF gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Research, 62(4), 1148\u20131151.","journal-title":"Cancer Research"},{"issue":"8","key":"3017_CR46","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/cncr.23335","volume":"112","author":"MY Kang","year":"2008","unstructured":"Kang, M. Y., Lee, B. B., Ji, Y. I., Jung, E. H., Chun, H. K., Song, S. Y., Park, S. E., Park, J., & Kim, D. H. (2008). Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer. Cancer, 112(8), 1699\u20131707.","journal-title":"Cancer"},{"issue":"9","key":"3017_CR47","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1007\/10350-007-0302-x","volume":"50","author":"T Moriyama","year":"2007","unstructured":"Moriyama, T., Matsumoto, T., Nakamura, S. Y., Mibu, R., Yao, T., & Iida, M. (2007). Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis. Diseases of the Colon and Rectum, 50(9), 1384\u20131392.","journal-title":"Diseases of the Colon and Rectum"},{"issue":"7","key":"3017_CR48","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/ajg.2010.22","volume":"105","author":"MM Garrity-Park","year":"2010","unstructured":"Garrity-Park, M. M., Loftus, E. V., Sandborn, W. J., Brayant, S., & Symrck, T. (2010). Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer. American Journal of Gastroenterology, 105(7), 1610\u20131619.","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"3017_CR49","first-page":"129","volume":"60","author":"M Esteller","year":"2000","unstructured":"Esteller, M., Tortola, S., Toyota, M., Capella, G., Peinado, M. A., Baylin, S. B., & Herman, J. G. (2000). Hypermethylation-associated inactivation of p14(ARF) is independent of p16 (INK4a) methylation and p53 mutational status. Cancer Research, 60(1), 129\u2013133.","journal-title":"Cancer Research"},{"issue":"2","key":"3017_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/labinvest.3780230","volume":"81","author":"N Burri","year":"2001","unstructured":"Burri, N., Shaw, P., Bouzourene, H., Sordat, I., Sordat, B., Gillet, M., Schorderet, D., Bosman, F. T., & Chaubert, P. (2001). Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Labatory Investigation, 81(2), 217\u2013229.","journal-title":"Labatory Investigation"},{"issue":"4","key":"3017_CR51","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s12253-011-9388-5","volume":"17","author":"F Naghibalhossaini","year":"2011","unstructured":"Naghibalhossaini, F., Hosseini, H. M., Mokarram, P., & Zamani, M. (2011). High frequency of genes\u2019 promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients. Pathology & Oncology Research, 17(4), 819\u2013825.","journal-title":"Pathology & Oncology Research"},{"issue":"7","key":"3017_CR52","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1245\/s10434-009-0901-y","volume":"17","author":"JC Kim","year":"2010","unstructured":"Kim, J. C., Choi, J. S., Roh, S. A., Cho, D. H., Kim, T. W., & Kim, Y. S. (2010). Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas. Annals of Surgical Oncology, 17(7), 1767\u20131776.","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"3017_CR53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1476-4598-3-28","volume":"3","author":"GE Lind","year":"2004","unstructured":"Lind, G. E., Thorstensen, L., L\u00f8vig, T., Meling, G. I., Hamelin, R., Rognum, T. O., et al. (2004). A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Molecular Cancer, 3(1), 28.","journal-title":"Molecular Cancer"},{"issue":"11","key":"3017_CR54","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/carcin\/21.11.2057","volume":"21","author":"S Zheng","year":"2000","unstructured":"Zheng, S., Chen, P., McMillan, A., Lafuente, A., Lafuente, M. J., Ballesta, A., Trias, M., & Wiencke, J. K. (2000). Correlations of partial and extensive methylation at the p14ARF locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis, 21(11), 2057\u20132064.","journal-title":"Carcinogenesis"},{"issue":"3","key":"3017_CR55","first-page":"1","volume":"11","author":"Z Zhou","year":"2016","unstructured":"Zhou, Z., Zhang, H., Lai, J., Diao, D., Li, W., Dang, C., & Song, Y. (2016). Relationships between p14ARF gene methylation and clinicopathological features of colorectal cancer: a meta-analysis. Colorectal cancer: a meta-analysis. PLoS ONE, 11(3), 1\u201312.","journal-title":"PLoS ONE"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-019-03017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12010-019-03017-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-019-03017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T23:55:34Z","timestamp":1586822134000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12010-019-03017-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["3017"],"URL":"https:\/\/doi.org\/10.1007\/s12010-019-03017-x","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"type":"print","value":"0273-2289"},{"type":"electronic","value":"1559-0291"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"2 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Faculty\u2019s Ethics committee (ethical code, 17100666) and in concordance to Helsinki II declaration. All participants gave informed consent before the study start.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}